OKUR Stock Summary and Trading Ideas (Onkure Therapeutics - Class A | NASDAQ:OKUR)

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research.

Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.

As of December 19, 2025, OKUR stock price declined to $3.01 with 231,735 million shares trading.

OKUR has a beta of 2.00, meaning it tends to be more sensitive to market movements. OKUR has a correlation of 0.13 to the broad based SPY ETF.

OKUR has a market cap of $40.78 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, VXF, IBB, IWC, BIB.

OKUR has underperformed the market in the last year with a price return of -62.6% while the SPY ETF gained +18.1%. However, in the short term, OKUR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +17.1% vs +2.8% return in SPY. But in the last 2 weeks, OKUR shares have been beat by the market, returning -1.6% compared to an SPY return of -0.5%.

OKUR support price is $2.88 and resistance is $3.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.